Markets
We collaborate with our clients to advance health care and drive transformation, together.
Our collaborations unlock new possibilities, shape policies, and improve health outcomes. We empower change and drive impact, working towards a future where health care reaches its full potential for the benefit of all.
Federal
Our collaboration with federal agencies propels impactful research, evaluation, and analysis that drive evidence-based health care policies and programs. We tackle complex health care challenges at a national level by providing federal decision-makers with timely, reliable data and actionable insights that positively impact population health and well-being.
- Agency for Healthcare Research and Quality (AHRQ)
- Centers for Disease Control and Prevention (CDC)
- Centers for Medicare & Medicaid Services (CMS)
- Federal Emergency Management Agency (FEMA)
- Health Resources and Services Administration (HRSA)
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Contracting vehicles
GSA MAS
Schedule
CMS
RMADA
CMS
MIDS
CDC
SHEPheRD
Pharmaceutical, biotech, and life science companies
We are trusted partners to pharmaceutical, biotech, and life science companies, offering cutting-edge research and analysis services and access to real-world evidence. We empower organizations to make informed decisions, contribute to regulatory submissions, devise market access strategies, and enhance post-marketing surveillance for improved patient outcomes and informed decision-making within the dynamic health care industry.
- Akebia Therapeutics, Inc.
- Albireo Pharma
- Amgen
- AstraZeneca Pharmaceuticals LP
- Bard Peripheral Vascular, Inc.
- Baxter Healthcare Corporation
- Bayer
- Cara Therapeutics
- Dialyze Direct, LLC
- Fibrogen, Inc.
- Fresenius Medical Care Asia-Pacific Ltd.
- GlaxoSmithKline LLC
- Horizon Therapeutics USA, Inc.
- Intercept Pharmaceuticals, Inc.
- Ipsen (f/k/a Albireo AB)
- Keryx Biopharmaceuticals, Inc.
- Merck Sharp & Dohme Corp.
- Mirum Pharmaceuticals
- Outset Medical
- Reata Pharmaceuticals
- Takeda Development Center Americas
- United HealthCare Services, Inc.
- CSL-Vifo
Foundations and private organizations
Our partnerships with foundations and private organizations fuel positive change in health care. Our collaborative approach ensures that philanthropic efforts are evidence-based, data-driven, and yield meaningful results, empowering organizations to make informed decisions and positively impact the communities they serve.
- Alport Syndrome Foundation (ASF)
- Beth Israel Deaconess Medical Center, Department of Medicine, Division of Nephrology
- Blue Cross Blue Shield Foundation of Michigan
- Bordeaux University Hospital
- The Children’s Hospital of Philadelphia (CHOP)
- Duke University
- Giannina Gaslini Institute
- International Society of Nephrology
- Japanese Society for Peritoneal Dialysis
- Keele University
- The Kidney Foundation, Japan (KFJ)
- Klinikum rechts der Isar der Technischen Universitat Munchen
- Kyowa Kirin, Co., Ltd. (f/k/a Kyowa Hakko Kirin Co.)
- Kyungpook National University Hospital-Driven Hospital
- Medical Technology and Practice Patterns Institute, Inc.
- Medical University of Vienna
- Montefiore Medical Center
- New York University School of Medicine
- Ottawa Hospital Research Institute
- PRECEDE Consortium, Inc.
- Project Purple
- PSC Partners Seeking a Cure (non-profit)
- The RAND Corporation
- Realm IDX
- The Regents of the University of Michigan
- The Research Institute at Nationwide Children’s Hospital
- TrovaNow
- Trustees of the University of Pennsylvania
Conflict of Interest Policy
As part of Arbor Research’s commitment to the health care community, key stakeholders, and consumers, we hold ourselves to the highest standards of research integrity, including matters of conflict of interest. We promote objectivity in research by establishing policies and procedures that provide a reasonable expectation that the design, conduct, and reporting of research will be free from bias resulting from organizational conflicts of interests, financial conflicts of interest, and personal conflicts of interests (including conflicts of commitment). These policies reflect our Statement of Values and Code of Ethics, and require disclosures by staff and members of the board of directors. Interests both at an individual level and at an organizational level are reviewed and managed.
Our policies and procedures are in compliance with, and may exceed, the federal regulations defined in the U.S. Department of Health and Human Services Final Rule on Financial Conflicts of Interest and the associated sections of 42 CFR Part 50, Subpart F and 45 CFR Part 94, in addition to any applicable directives from other funding or government sources, Federal Acquisition Regulation Subpart 9.5, and Federal Acquisition Regulation Part 3.
For more detail, please read our Arbor Research Conflict of Interest Policy.
Partnerships
Scientific collaboration
Arbor Research collaborates closely with faculty and researchers from other major research organizations in the United States and around the world to perform research that affects clinical practice, policy development, and medical payment systems.
Small business partnerships
Arbor Research strives to support small businesses through partnerships and subcontracting opportunities. We work with small businesses certified through the Small Disadvantaged Business (SDB), 8(a) Business Development, and HUBZone Empowerment programs, including minority-owned, women-owned (WOSB), veteran-owned (SVOB), service-disabled veteran-owned (SDVOSB), and other disadvantaged small businesses.
Learn more
For more information about collaborating with Arbor Research, please contact:
Sponsored Projects
3989 Research Park Dr.
Ann Arbor, MI 48108
Tel: +1 (734) 665-4108
Fax: +1 (734) 665-2103
SponsoredProjects@arborresearch.org